pravilnik o listi lekova koji se propisuju i izdaju na teret sredstava ...

More documents

Recommendations

Info

NAPOME NA Lek se uvodi u terapiju na osnovu mišljenja: 1. Klinike za infektivne i tropske bolesti Kliničkog centra Srbije; 2. Klinike za infektivne bolesti Kliničkog centra Niš; 3. Klinike za infektivne bolesti Kliničkog centra Vojvodine; 4. Klinike za infektivne bolesti Kliničkog centra Kragujevac. Lista A - Grupa L. Lekovi koji se propisuju i izdaju na obrascu lekarskog recepta JKL ATC INN 1030 223 1030 222 1030 221 1039 285 Zaštićen o ime leka FO Pako vanje i jačina leka Naziv proizvođ ača leka Držav a proizv odnje leka Cena leka na velik o za pako vanje L ANTINEOPLASTICI I IMUNOMODULATORI L01 ANTINEOPLASTICI L01C Biljni alkaloidi i drugi prirodni proizvodi L01C Derivati podofilotoksina B L01C B01 etopozid L01C B01 L01C B01 L01C B01 etopozid LASTET CAP. 25 etopozid LASTET CAP. 50 kapsula kapsula etopozid LASTET CAP. 100 kapsula blister , 40 po 25 mg blister , 20 po 50 mg blister , 10 po 100 mg Nippon Kayaku Co. Ltd. Nippon Kayaku Co. Ltd. Nippon Kayaku Co. Ltd. L01X Ostali antineoplastici L01X X L01X X05 hidroksikarbamid L01X X05 INDIKACIJ E hidroksik arbamid LITALIR kapsula Ostali antineoplastici bočic a, 100 po 500 mg Bristol Myers- Squibb S.R.L. Japan 10.16 3,70 Japan 10.16 3,70 Japan 10.16 3,70 Italija 3.791, 50 D D D Cen a leka na velik o po DDD Partici pacija osigur anog lica - - 50,00 - - 50,00 - - 50,00 - - 50,00 Hronične mijeloproliferativne bolesti (hronična granulocitna leukemija, esencijalna trombocitemija, primarna mijelofibroza, prava policitemija) ,
1031 043 prema Pravilniku o standardima za primenu citostatika. L01X X11 estramustin L01X X11 estramus tin ESTRAC YT kapsula 100 po 140 mg Pfizer Italia S.R.L. Italija 10.37 5,80 - - 50,00 Karcinom prostate, hormon refraktorni, u slučaju kontraindikacija za INDIKACIJ primenu docetaksela, PS 0, 1 ili 2, prema Pravilniku o standardima za E primenu citostatika L02 ENDOKRINOLOŠKA TERAPIJA L02A Hormoni i srodni lekovi L02A Progestogeni B L02A B01 megestrol 3048 912 1048 911 1048 913 3048 814 3048 951 L02A B01 L02A B01 L02A B01 L02A B01 L02A B01 INDIKACIJ E megestro l megestro l megestro l megestro l megestro l MEGACE oralna suspenzij a MEGACE tableta MEGACE tableta O' TENTIKA MEGOXI oralna suspenzij a oralna suspenzij a boca plastič na, 1 po 240 ml (40 mg/ml ) bočic a, 100 po 160 mg bočic a, 30 po 160 mg boca plastič na, 1 po 240ml (40 mg/ml ) boca plastič na, 1 po240 ml (40 mg/ml ) Bristol Myers- Squibb Bristol Myers- Squibb Bristol Myers- Squibb Vipharm S.A. PharmaS wiss d.o.o. Francu ska Francu ska Francu ska 7.929, 90 12.93 1,20 3.879, 40 7.929, Poljska 90 Republ ika Srbija 7.929, 90 16 0 m g 16 0 m g 16 0 m g 16 0 m g 16 0 m g 132, 17 50,00 129, 31 50,00 129, 31 50,00 132, 17 50,00 132, 17 50,00 Terapija nevoljnog značajnog gubitka telesne težine kod pacijenata sa nehematološkim malignitetima (solidnim tumorima) . Pacijenti moraju imati
Page 1 and 2:
PRAVILNIK O LISTI LEKOVA KOJI SE PR
Page 3 and 4:
Lista D sadrži sledeće podatke o
Page 5 and 6:
Danom stupanja na snagu ovog pravil
Page 7 and 8:
1122 863 A02B C02 INDIKACIJ E NAPOM
Page 9 and 10:
100 A02 on ON tableta , 10 po 1 mg
Page 11 and 12:
INDIKACIJ E NAPOME NA A07 D A07 DA
Page 13 and 14:
0041 413 0041 414 0041 425 0041 533
Page 15 and 16:
0041 549 A10 AB0 6 A10A B06 NAPOME
Page 17 and 18:
NAPOME NA A10 AD A10 AD0 1 0041 558
Page 19 and 20:
0041 528 A10 AD0 5 A10A D05 NAPOME
Page 21 and 22: NAPOME NA 1043 060 1043 062 1043 07
Page 23 and 24: 1042 830 1042 831 1042 832 1042 833
Page 25 and 26: 3060 073 3060 050 1061 040 1061 050
Page 27 and 28: 1101 402 1101 440 1101 354 C01B D01
Page 29 and 30: 1103 C02C doksazo ALPHAPR 765 A04 s
Page 31 and 32: 1107 886 1107 885 1107 580 1107 582
Page 33 and 34: 1107 C07A karvedil 673 G02 ol 1107
Page 35 and 36: 1402 858 1402 850 1402 851 C08C A01
Page 37 and 38: 1103 872 1103 177 1103 175 1103 887
Page 39 and 40: 1103 013 1103 083 1103 082 1103 251
Page 41 and 42: INDIKACIJ E 1401 130 1401 131 1401
Page 43 and 44: 1104 482 1104 483 1104 485 1104 486
Page 45 and 46: JKL ATC INN 4157 201 4157 202 4157
Page 47 and 48: 220 C02 cetonid, neomicin 4153 221
Page 49 and 50: 1142 200 G02C .. heksopre nalin GYN
Page 51 and 52: 0044 309 H01A C01 INDIKACIJ E NAPOM
Page 53 and 54: 1047 632 1047 511 1040 050 1040 230
Page 55 and 56: 202 114 7 102 114 5 102 114 8 302 1
Page 57 and 58: 302 160 9 302 156 8 J01 CR0 2 J01 C
Page 59 and 60: 332 164 4 2 J01 DC0 2 INDIKACI JE N
Page 61 and 62: 332 555 3 132 555 4 J01F A01 J01F A
Page 63 and 64: 332 557 0 332 547 3 332 547 4 332 5
Page 65 and 66: 940 0 132 940 1 MA0 2 J01 MA0 2 IND
Page 67 and 68: 132 862 1 132 862 2 J05A E.. J05A E
Page 69 and 70: 132 837 6 AF0 5 J05A F05 INDIKACI J
Page 71: 132 839 3 NA 1. Klinike za infektiv
Page 75 and 76: 1039 720 L02B G03 INDIKACIJ E NAPOM
Page 77 and 78: 083 A06 na kiselina INDIKACIJ E NAP
Page 79 and 80: 1034 330 1034 331 L04A X03 metotrek
Page 81 and 82: 3087 302 3087 303 3087 301 3087 304
Page 83 and 84: 9087 N02A 567 B03 9087 569 9087 805
Page 85 and 86: 1087 651 1087 700 3086 695 3086 742
Page 87 and 88: 1084 070 1084 060 3084 532 1084 530
Page 89 and 90: 1084 081 1084 082 1084 083 1084 126
Page 91 and 92: 1084 612 N03A X12 INDIKACIJ E NAPOM
Page 93 and 94: 1085 307 N04B A02 INDIKACIJ E NAPOM
Page 95 and 96: 1070 885 A N05A F N05A H N05A N N05
Page 97 and 98: INDIKACIJ E 1. Šizofrenija, šizot
Page 99 and 100: 1071 750 1071 751 1071 752 1071 330
Page 101 and 102: E 2. Rekurentni depresivni poremeć
Page 103 and 104: 644 B06 tableta 28 po 50 mg 1072 64
Page 105 and 106: 091 B01 m 500 mg -Industria alija;
Page 107 and 108: 7110 310 7110 311 D09 R01A D09 R01A
Page 109 and 110: INDIKACIJ E NAPOMEN A 7114 725 7114
Page 111 and 112: 7114 680 7114 681 R03B A01 R03B A01
Page 113 and 114: 7114 596 R03B A05 flutikazo n FLIXO
Page 115 and 116: 1114 750 1114 753 R03D C03 R03D C03
Page 117 and 118: 4090 620 7094 033 7096 050 S01B A S
Page 119 and 120: INDIKACIJ E NAPOMEN A S01E E04 7099
Page 121 and 122: 1122 858 1122 846 A02B C01 A02B C01
Page 123 and 124:
1122 910 1122 911 A02B C03 A02B C03
Page 125 and 126:
471 C02 n LK 250 stentna tableta 11
Page 127 and 128:
1050 121 4 A11C C04 INDIKACIJ E NAP
Page 129 and 130:
Lista A1 - Grupa C. Lekovi koji se
Page 131 and 132:
C07A B Beta adrenergički blokatori
Page 133 and 134:
1103 632 1103 630 1103 631 1103 220
Page 135 and 136:
1401 906 1401 174 1401 260 1401 261
Page 137 and 138:
1103 150 1103 151 1103 899 1103 594
Page 139 and 140:
1401 924 1401 926 1401 925 1401 650
Page 141 and 142:
1104 C10A simvast 614 A01 atin INDI
Page 143 and 144:
4155 571 4155 570 leka jačina leka
Page 145 and 146:
4153 440 4153 441 7153 442 9150 024
Page 147 and 148:
1135 231 1135 232 G03 POLNI HORMONI
Page 149 and 150:
1048 G03D didroge 293 B01 steron DU
Page 151 and 152:
INDIKACIJ 1. Benigna hiperplazija p
Page 153 and 154:
1021 607 1021 566 1021 567 1021 560
Page 155 and 156:
1325 300 1325 200 2. Zapaljenje sre
Page 157 and 158:
1326 226 1326 228 1326 222 1329 350
Page 159 and 160:
1327 506 J02A C02 INDIKACIJ E NAPOM
Page 161 and 162:
1162 487 1162 190 1162 193 1162 207
Page 163 and 164:
1162 M01A ibuprof 532 E01 en 1162 5
Page 165 and 166:
E NAPOMEN Lek se propisuje na osnov
Page 167 and 168:
908 756 9 908 780 5 908 780 8 908 7
Page 169 and 170:
108 672 9 108 672 8 108 687 6 108 6
Page 171 and 172:
534 3 108 534 4 108 534 8 108 534 9
Page 173 and 174:
107 097 0 107 097 1 N05 AF N05 AF0
Page 175 and 176:
207 092 4 207 093 6 AX0 8 N05 AX0 8
Page 177 and 178:
0 3 po 30 mg INDIKACI JE NAPOME NA
Page 179 and 180:
NAPOME NA 107 901 0 107 901 1 107 9
Page 181 and 182:
0 4 50 mg 118 203 1 N07 BB0 4 INDIK
Page 183 and 184:
7114 671 7114 672 R03A K06 R03A K06
Page 185 and 186:
7114 721 R03B A02 INDIKACIJ E NAPOM
Page 187 and 188:
NAPOMEN Samo za decu do 6 godina st
Page 189 and 190:
7090 813 4090 921 7094 070 7094 080
Page 191 and 192:
0122 120 C A02B C01 omeprazol A02B
Page 193 and 194:
nfuziju ml NAPOMEN STAC; Lek se uvo
Page 195 and 196:
0051 845 0051 351 0050 150 0050 151
Page 197 and 198:
006 203 5 006 203 6 006 203 7 006 2
Page 199 and 200:
220 0 006 220 1 006 220 2 006 220 3
Page 201 and 202:
006 241 1 B01 AB0 8 INDIKACI JE 006
Page 203 and 204:
906 708 2 B02 BC3 0 NAPOME NA B02 B
Page 205 and 206:
006 663 2 006 615 3 006 615 4 006 6
Page 207 and 208:
006 690 1 006 690 9 006 691 0 006 6
Page 209 and 210:
006 620 0 006 620 1 006 620 2 006 6
Page 211 and 212:
006 025 0 B03 AC0 2 B03 AC0 2 NAPOM
Page 213 and 214:
017 934 0 017 934 5 017 934 6 B05 A
Page 215 and 216:
017 131 1 017 131 2 B05 BA0 2 B05 B
Page 217 and 218:
130 6 017 130 3 017 130 5 017 403 7
Page 219 and 220:
017 112 2 B05 BA1 0 glicerofosfat,
Page 221 and 222:
017 112 4 B05 BA1 0 alanin, arginin
Page 223 and 224:
017 541 0 017 518 5 040 015 6 040 0
Page 225 and 226:
917 573 3 917 573 4 917 573 5 B05 D
Page 227 and 228:
917 574 1 B05 D... alanin, valin, m
Page 229 and 230:
917 574 4 917 574 5 917 572 0 917 5
Page 231 and 232:
917 575 4 917 575 6 917 575 8 917 5
Page 233 and 234:
917 511 9 917 511 8 917 572 6 917 5
Page 235 and 236:
013 311 0 017 551 0 017 518 0 017 5
Page 237 and 238:
906 1 AA0 2 JKL ATC INN 0100 250 01
Page 239 and 240:
0103 290 0103 291 C02C A C02C A06 u
Page 241 and 242:
41561 51 41561 50 41561 52 41561 63
Page 243 and 244:
014 210 2 004 861 9 004 846 8 413 7
Page 245 and 246:
INDIKACI JE NAPOME NA G03 GA0 5 004
Page 247 and 248:
014 011 6 H01B B02 NAPOME NA H01 C
Page 249 and 250:
004 728 6 004 714 0 004 721 9 004 7
Page 251 and 252:
004 712 1 004 712 2 H02A B09 H02A B
Page 253 and 254:
002 156 5 002 165 0 J01 CR0 2 J01 C
Page 255 and 256:
032 164 0 032 164 3 032 188 2 032 1
Page 257 and 258:
0 2 rastvor za injekciju 032 160 1
Page 259 and 260:
198 8 032 186 5 032 186 3 032 199 6
Page 261 and 262:
8 2 PHARMAN OVA 002 975 5 002 975 6
Page 263 and 264:
622 3 F01 YCIN-MIP za injekciju NAP
Page 265 and 266:
940 3 MA0 2 NAPOME NA J01 MA1 2 032
Page 267 and 268:
102 905 0 002 906 0 002 906 1 XX0 8
Page 269 and 270:
NAPOME **; Samo u zdravstvenim usta
Page 271 and 272:
001 351 0 001 351 1 001 346 2 001 3
Page 273 and 274:
001 344 5 J06 BB0 1 NAPOME NA J06 B
Page 275 and 276:
2 5 besnila SKI IMUNOGL OBULIN 001
Page 277 and 278:
001 114 7 J07A J51 NAPOME NA J07A L
Page 279 and 280:
001 186 5 NA J07A vakcina protiv di
Page 281 and 282:
001 155 1 001 189 1 001 190 4 001 1
Page 283 and 284:
NAPOME NA nziju za injekcij u i.j./
Page 285 and 286:
0034 801 0034 800 L01B B05 L01B B05
Page 287 and 288:
0034 212 0034 215 0034 216 0034 214
Page 289 and 290:
242 A04 in BIN "Ebewe" 0030 111 003
Page 291 and 292:
0033 190 0033 191 0033 102 0033 103
Page 293 and 294:
0033 L01D epirubic EPISINDA 130 B03
Page 295 and 296:
240 A02 atin ATIN at za rastvor za
Page 297 and 298:
0031 503 0031 502 L01X A03 L01X A03
Page 299 and 300:
JE 2. Medikamentna kastracija za ka
Page 301 and 302:
0328 336 0328 337 0328 339 0328 645
Page 303 and 304:
0039 421 L03A X L03A X03 L03A X03 3
Page 305 and 306:
0162 M01 440 AB05 0162 192 1162 520
Page 307 and 308:
0082 301 DeltaSele ct ATRACU M03 at
Page 309 and 310:
NAPOME NA gastroenterologa: - o pos
Page 311 and 312:
757 5 AH0 2 NAPOME NA N01 AH0 3 008
Page 313 and 314:
008 158 3 N01 BB0 1 NAPOME NA N01 B
Page 315 and 316:
753 3 008 643 1 008 693 0 008 452 0
Page 317 and 318:
NAPOME NA N05 AD N05 AD0 1 007 020
Page 319 and 320:
007 112 3 007 183 4 007 183 5 007 1
Page 321 and 322:
005 833 4 011 915 0 3 R06 AC0 3 hlo
Page 323 and 324:
0184 036 0184 025 0184 100 0184 105
Page 325 and 326:
0199 215 0199 217 V08A B02 V08A B02
Page 327 and 328:
0199 415 0199 416 0199 407 0199 408
Page 329 and 330:
3192 101 0199 430 0199 015 0199 021
Page 331 and 332:
020 A01 etska kiselina 0199 010 019
Page 333 and 334:
0069 150 0069 152 0069 154 0069 155
Page 335 and 336:
0069 226 0069 227 0069 230 0069 231
Page 337 and 338:
0069 938 0069 924 0069 928 0069 929
Page 339 and 340:
0069 921 0069 923 0069 927 B03X A02
Page 341 and 342:
214 A03 etilenglik ol - epoetin bet
Page 343 and 344:
0034 413 A04 L01B A04 INDIKACIJ E p
Page 345 and 346:
prva linija za metastatsku bolest b
Page 347 and 348:
INDIKACIJ E 1. Karcinom kolorektuma
Page 349 and 350:
Lokalno odmakli i/ili metastatski k
Page 351 and 352:
0328 630 0328 631 0328 900 0328 632
Page 353 and 354:
NAPOMEN A L03A X L03A X13 0015 120
Page 355 and 356:
) prisustvo perifernog artritisa i
Page 357 and 358:
INDIKACIJ E NAPOMEN A M05B A03 0059
Page 359 and 360:
0059 222 M05B A08 INDIKACIJ E NAPOM
Page 361 and 362:
N00272 5 N00211 3 N00210 5 N00106 5
Page 363 and 364:
2 mcg N00126 3 H02AA02 fludrocortiz
Page 365 and 366:
N00302 0 N00278 2 N00280 8 N00281 6
Page 367 and 368:
N00243 6 N00148 7 N00149 5 N00150 3
Page 369 and 370:
N00254 3 N00333 5 N00334 3 N00335 0
Page 371 and 372:
N00342 6 N00343 4 N00344 2 N00269 1
Page 373:
N00253 5 N00191 7 N00192 5 N00193 3
show all

pravilnik o listi lekova koji se propisuju i izdaju na teret sredstava ...

Create successful ePaper yourself

Delete template?

Save as template?